Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCrystal Amber Regulatory News (CRS)

Share Price Information for Crystal Amber (CRS)

Share Price is delayed by 15 minutes
Get Live Data
104.00    0.00 (0.00%)
Bid:
102.00
Ask:
106.00
Spread: 4.00 (3.922%)
Market Cap: £61.92m
CRS Live PriceLast checked at - London Stock Exchange

Intraday Crystal Amber Share Chart

Update on shareholder returns

30 Jun 2022 07:00

RNS Number : 7196Q
Crystal Amber Fund Limited
30 June 2022
 

The information contained within this announcement is deemed by the Company to constitute inside information pursuant to Article 7 of EU Regulation 596/2014 as it forms part of UK domestic law by virtue of the European Union (Withdrawal) Act 2018 as amended.

 

30 June 2022

 

Crystal Amber Fund Limited

 

(the "Company" or the "Fund")

 

Update on shareholder returns

 

The Fund previously announced, based on the Investment Manager's assessment of the status and timing of anticipated corporate transactions, that it was targeting additional shareholder returns of at least £40 million or 50 pence per Share before 30 June 2022. The payment of the 10p a share dividend to Shareholders on 9 February 2022, representing a gross return of £8.3 million, was the first shareholder return towards achieving that target.

 

As stated in the Company's circular to convene an EGM (extraordinary general meeting), dated 15 February 2022, the Fund, having consulted with several shareholders, determined it was no longer considered to be in the interests of the Fund to impose a fixed deadline but would retain 30 June 2022 as a target.

 

The Fund is pleased to provide an update on shareholder returns based on the Investment Manager's and the Board's current assessment of the status and timing of anticipated corporate transactions. Following the payment of the 10p a share dividend to shareholders in February 2022 (representing a gross return of £8.3 million), the Fund expects to return a further 10p a share (representing a gross return of £8.3 million) by mid-August 2022 and to have returned an additional 60p a share (equivalent to £50 million) by the end of September 2022. If these distributions can be achieved, this would bring total returns in the first nine months of 2022 to 80p a share (equivalent to £66.6 million).

 

 

For further enquiries please contact:

 

Crystal Amber Fund Limited

Chris Waldron (Chairman)

Tel: 01481 742 742

 

Allenby Capital Limited - Nominated Adviser

David Worlidge/Liz Kirchner

Tel: 020 7167 6431

 

Winterflood Securities - Broker

Joe Winkley/Neil Langford

Tel: 020 3100 0160

 

Crystal Amber Advisers (UK) LLP - Investment Adviser

Richard Bernstein

Tel: 020 7478 9080

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
MSCKZGZVNLDGZZM
Date   Source Headline
22nd Dec 20254:48 pmRNSTransaction in Own Shares and Total Voting Rights
19th Dec 20255:04 pmRNSTransaction in Own Shares and Total Voting Rights
19th Dec 20255:04 pmRNSTransaction in Own Shares and Total Voting Rights
18th Dec 20254:57 pmRNSTransaction in Own Shares and Total Voting Rights
18th Dec 20254:57 pmRNSTransaction in Own Shares and Total Voting Rights
17th Dec 20255:57 pmRNSTransaction in Own Shares and Total Voting Rights
17th Dec 20254:15 pmRNSMonthly Net Asset Value
16th Dec 20255:19 pmRNSTransaction in Own Shares and Total Voting Rights
15th Dec 20256:18 pmRNSTransaction in Own Shares and Total Voting Rights
15th Dec 20257:00 amRNSTransaction in Own Shares and Total Voting Rights
11th Dec 20255:43 pmRNSTransaction in Own Shares and Total Voting Rights
11th Dec 20257:00 amRNSDirector/PDMR Shareholding
9th Dec 20255:42 pmRNSTransaction in Own Shares and Total Voting Rights
8th Dec 20255:36 pmRNSTransaction in Own Shares and Total Voting Rights
5th Dec 20255:00 pmRNSTransaction in Own Shares and Total Voting Rights
4th Dec 20255:41 pmRNSTransaction in Own Shares and Total Voting Rights
3rd Dec 202510:17 amRNSShare Buyback Programme
2nd Dec 20251:08 pmRNSResult of AGM
1st Dec 20257:00 amRNSTransaction in Own Shares and Total Voting Rights
24th Nov 20256:07 pmRNSTransaction in Own Shares and Total Voting Rights
21st Nov 20256:30 pmRNSTransaction in Own Shares and Total Voting Rights
20th Nov 20257:00 amRNSShare Buyback Programme
20th Nov 20257:00 amRNSMonthly Net Asset Value
18th Nov 20257:00 amRNSDirector/PDMR Shareholding
17th Nov 20256:05 pmRNSTransaction in Own Shares and Total Voting Rights
17th Nov 20255:59 pmRNSHolding(s) in Company
14th Nov 20256:11 pmRNSTransaction in Own Shares and Total Voting Rights
14th Nov 20257:05 amRNSProposed change of strategy and investment manager
13th Nov 20255:39 pmRNSTransaction in Own Shares and Total Voting Rights
6th Nov 20257:00 amRNSNotice of AGM
31st Oct 20255:30 pmRNSTotal Voting Rights
27th Oct 20256:13 pmRNSTransaction in Own Shares and Total Voting Rights
24th Oct 20259:51 amRNSMonthly Net Asset Value
24th Oct 20259:50 amRNSMonthly Net Asset Value
24th Oct 20259:48 amRNSMonthly Net Asset Value
24th Oct 20259:47 amRNSMonthly Net Asset Value
20th Oct 20256:29 pmRNSTransaction in Own Shares and Total Voting Rights
20th Oct 202511:11 amRNSShare Buyback Programme
17th Oct 20257:00 amRNSFinal Results
16th Oct 20257:00 amRNS-RInvestor Presentation by Morphic Medical Inc
7th Oct 20257:00 amRNS-RInvestor Presentation by Morphic Medical Inc
30th Sep 20255:00 pmRNSTransaction in Own Shares and Total Voting Rights
29th Sep 20255:04 pmRNSTransaction in Own Shares and Total Voting Rights
25th Sep 20255:26 pmRNSTransaction in Own Shares and Total Voting Rights
22nd Sep 20257:00 amRNSTransaction in Own Shares and Total Voting Rights
17th Sep 20257:00 amRNSTransaction in Own Shares and Total Voting Rights
15th Sep 20257:00 amRNS-RMorphic Medical Inc. appoints new CFO
10th Sep 20255:21 pmRNSTransaction in Own Shares and Total Voting Rights
4th Sep 20255:29 pmRNSTransaction in Own Shares and Total Voting Rights
2nd Sep 20255:31 pmRNSTransaction in Own Shares and Total Voting Rights

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.